ASCP Annual Meeting is the premiere each year in the field of psychopharmacology
The ASCP Annual Meeting is the premiere meeting each year in the field of psychopharmacology. Bringing together representatives from academia, the National Institutes of Health (NIH), Food and Drug Administration (FDA), European regulatory agencies and industry to discuss key aspects of neuropsychiatric drug development, including the impact of diagnostic changes and personalized interventions based on biomarkers or genetic information. A Steering Committee chaired by Drs. Susan Kornstein and Mark Rapaport with representation of the sectors that are part of the ASCP community lead the direction of the meeting. Representatives from the FDA, EMA, NIMH, NIDA, NIAAA, the pharmaceutical industry and academia comprise the 2022 Steering Committee. A Program Committee under the leadership of Drs. Erika Saunders and Lee Cohen are responsible for the review of all program submissions.
The 2023 SOBP Annual Meeting will provide an interactive platform for learning...
At ADAA's annual conference, you can advance your career, connect and network...
"Leading the Way: The Critical Importance of Nursing Science and Implementation in...
Conference Objectives: Re-Building meaningful connections through practice, advocacy, and researchThe COVID-19 pandemic...
The 46th Annual MidWinter Meeting will be held February 11-15, 2023 in...
Don’t miss another great year of WCBR. The annual meeting will be...
Created with AppPage.net
Similar Apps - visible in preview.